Clinical Trials Browser

Withdrawn × Temozolomide × 90 days × Clear all

NCT03554707 2026-05-08

SGT-53 in Children With Recurrent or Progressive CNS Malignancies

Phase EARLY_PHASE1 Withdrawn

Central Nervous System Neoplasms

NCT04105374 2026-05-07

Testing the Addition of an Anti-cancer Viral Gene Therapy, Toca 511/Toca FC, to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed Glioblastoma

Phase 2/3 Withdrawn

Astrocytoma, Glioblastoma, Oligodendroglioma